Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus.
about
Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery.A novel option for prandial insulin therapy: inhaled insulin.Place of technosphere inhaled insulin in treatment of diabetes.Evaluation of Bacillus subtilis SPB1 biosurfactant effects on hyperglycemia, angiotensin I-converting enzyme (ACE) activity and kidney function in rats fed on high-fat-high-fructose diet.Assessment of the antidiabetic and antilipidemic properties of Bacillus subtilis SPB1 biosurfactant in alloxan-induced diabetic rats.
P2860
Inhaled technosphere insulin: a novel delivery system and formulation for the treatment of types 1 and 2 diabetes mellitus.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Inhaled technosphere insulin: ...... pes 1 and 2 diabetes mellitus.
@en
type
label
Inhaled technosphere insulin: ...... pes 1 and 2 diabetes mellitus.
@en
prefLabel
Inhaled technosphere insulin: ...... pes 1 and 2 diabetes mellitus.
@en
P2093
P2860
P356
P1433
P1476
Inhaled technosphere insulin: ...... pes 1 and 2 diabetes mellitus.
@en
P2093
Anne J Kugler
Daniel A Nadeau
David Q Pham
Kristin L Fabbio
P2860
P304
P356
10.1002/PHAR.1555
P407
P577
2015-03-01T00:00:00Z